Cytta Corp.
Cytta Corp. Fundamental Analysis
Cytta Corp. (CYCA) shows moderate financial fundamentals with a PE ratio of 3.11, profit margin of 64.24%, and ROE of 1.17%. The company generates $0.0B in annual revenue with weak year-over-year growth of -85.06%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -20.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CYCA's fundamental strength across five key dimensions:
Efficiency Score
ExcellentCYCA demonstrates superior asset utilization.
Valuation Score
ExcellentCYCA trades at attractive valuation levels.
Growth Score
ModerateCYCA shows steady but slowing expansion.
Financial Health Score
ExcellentCYCA maintains a strong and stable balance sheet.
Profitability Score
ModerateCYCA maintains healthy but balanced margins.
Key Financial Metrics
Is CYCA Expensive or Cheap?
P/E Ratio
CYCA trades at 3.11 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, CYCA's PEG of -0.17 indicates potential undervaluation.
Price to Book
The market values Cytta Corp. at 2.03 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -3.79 times EBITDA. This is generally considered low.
How Well Does CYCA Make Money?
Net Profit Margin
For every $100 in sales, Cytta Corp. keeps $64.24 as profit after all expenses.
Operating Margin
Core operations generate -55.27 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.17 in profit for every $100 of shareholder equity.
ROA
Cytta Corp. generates $48.46 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Cytta Corp. generates limited operating cash flow of $-1.45M, signaling weaker underlying cash strength.
Free Cash Flow
Cytta Corp. generates weak or negative free cash flow of $-1.46M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.00 in free cash annually.
FCF Yield
CYCA converts -16.96% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
3.11
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.17
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.03
vs 25 benchmark
P/S Ratio
Price to sales ratio
204.29
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.08
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.85
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
1.17
vs 25 benchmark
ROA
Return on assets percentage
0.48
vs 25 benchmark
ROCE
Return on capital employed
-0.56
vs 25 benchmark
How CYCA Stacks Against Its Sector Peers
| Metric | CYCA Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 3.11 | 34.36 | Better (Cheaper) |
| ROE | 116.71% | 1116.00% | Weak |
| Net Margin | 6423.53% | -125859.00% (disorted) | Strong |
| Debt/Equity | 0.08 | 7.88 | Strong (Low Leverage) |
| Current Ratio | 3.85 | 5.74 | Strong Liquidity |
| ROA | 48.46% | -308994.00% (disorted) | Strong |
CYCA outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Cytta Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-93.52%
Industry Style: Growth, Innovation, High Beta
DecliningEPS CAGR
-161.39%
Industry Style: Growth, Innovation, High Beta
DecliningFCF CAGR
-344.93%
Industry Style: Growth, Innovation, High Beta
Declining